Mortality in childhood progressive encephalopathy from 1985 to 2004 in Oslo, Norway: A population-based study

Acta Paediatrica, International Journal of Paediatrics

Volumn 97, Issue 1, 2008, Pages 35-40

  Strømme, Petter ^a,d   Magnus, Per ^b   Kanavin, Øivind Juris ^a   Rootwelt, Terje ^c   Woldseth, Berit ^c   Abdelnoor, Michael ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Metabolic diseases; Mortality; Neurodegenerative disorders; Progressive encephalopathy

Indexed keywords

ARTICLE; BRAIN DISEASE; CONFIDENCE INTERVAL; DEATH; DEGENERATIVE DISEASE; FATALITY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORTALITY; NEWBORN; NEWBORN PERIOD; NORWAY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

EID: 38349037597     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2007.00579.x     Document Type: Article

References (22)

1. Davies H. Living with dying: families coping with a child who has a neurodegenerative genetic disorder. Axone 1996 18 : 38 44.
2. Gravelle AM. Caring for a child with a progressive illness during the complex chronic phase: parents' experience of facing adversity. J Adv Nurs 1997 25 : 738 45.
3. Surtees R. Understanding neurodegenerative disorders. Curr Paediatr 2006 12 : 191 98.
4. Lary JM, Edmonds LD. Prevalence of spina bifida at birth - United States, 1983-1990: a comparison of two surveillance systems. MMWR CDC Surveill Summ 1996 45 : 15 26.
5. Persson EK, Hagberg G, Uvebrant P. Hydrocephalus prevalence and outcome in a population-based cohort of children born in 1989-1998. Acta Paediatr 2005 94 : 726 32.
6. Himmelmann K, Hagberg G, Beckung E, Hagberg B, Uvebrant P. The changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in the birth-year period 1995-1998. Acta Paediatr 2005 94 : 287 94.
7. Beck M. New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy. Hum Genet 2007 121 : 1 22.
8. Stromme P, Kanavin OJ, Abdelnoor M, Woldseth B, Rootwelt T, Diderichsen J, et al. Incidence rates of progressive childhood encephalopathies in Oslo, Norway: a population based study. BMC Pediatrics 2007 7 : 25.
9. Uvebrant P, Lanneskog K, Hagberg B. The epidemiology of progressive encephalopathies in childhood. I. Live birth prevalence in west Sweden. Neuropediatrics 1992 23 : 209 11.
10. World Health Organization. Manual of the international statistical classification of diseases, injuries, and causes of death. Geneva, 1967.
11. Klassifikasjon av sykdommer, skader og dødsårsaker: norsk utgave av International Classification of Diseases. Ninth revision (ICD-9). Oslo : Statistisk sentralbyrå, 1986.
12. World Health Organization. ICD-10. International statistical classification of diseases and related health problems. Tenth revision. 2nd ed. Geneva : World Health Organization, 2004.
13. Hennekens CH, Buring JE, Mayrent SL. Epidemiology in medicine. Boston : Little, Brown, 1987.
14. Lee ET, Wang JW. Statistical methods for survival data analysis. 3rd ed. Hoboken, NJ : John Wiley, 2003.
15. Bland M. An introduction to medical statistics. 3rd ed. Oxford : Oxford University Press, 2000.
16. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. New York, NY : Lippincott-Raven, 1998.
17. Davidson EJ, Silva TJ, Sofis LA, Ganz ML, Palfrey JS. The doctor's dilemma: challenges for the primary care physician caring for the child with special health care needs. Ambul Pediatr 2002 2 : 218 23.
18. Siintola E, Partanen S, Stromme P, Haapanen A, Haltia M, Maehlen J, et al. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 2006 129 : 1438 45.
19. Millat G, Chikh K, Naureckiene S, Sleat DE, Fensom AH, Higaki K, et al. Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group. Am J Hum Genet 2001 69 : 1013 21.
20. Hoffmann B, Mayatepek E. Neurological manifestations in lysosomal storage disorders - from pathology to first therapeutic possibilities. Neuropediatrics 2005 36 : 285 9.
21. Dickson P, McEntee M, Vogler C, Le S, Levy B, Peinovich M, et al. Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid. Mol Genet Metab 2007 91 : 61 8.
22. Wilcken B. Recent advances in newborn screening. J Inherit Metab Dis 2007 30 : 129 33.